US pharmacy giant buys rival for $29.1 billion

July 21, 2011

Pharmacy benefits manager Express Scripts said Thursday it had reached a deal to buy its competitor Medco Health Systems for $29.1 billion, ahead of looming changes in the US healthcare system.

Pharmacy benefits managers, or PBMs, work with employers and health insurers to obtain cheaper by pushing to give discounts on their often-pricey medicines.

The merger, if approved by regulators, would be a big step to consolidating the PBM industry at a time when President Barack Obama's initiative is poised to provide insurance to millions of Americans.

"The cost and quality of healthcare is a great concern to all Americans; this is the right deal at the right time for the right reasons," Express Scripts chief executive George Paz said in a statement.

Shares of Medco surged 14 percent on the New York Stock Exhange by midday, while Express Scripts stock was up 5.1 percent.

Under the terms of the deal, Medco shareholders would receive $71.36 in cash and Express Scripts stock for each of their shares, a premium of 28 percent to the closing price of Medco shares on Wednesday, the statement said.

The merger, which was unanimously approved by the boards of both companies, would leave Express Scripts shareholders with ownership of 59 percent of the combined firm.

If approved by shareholders and regulators, including antitrust authorities, the deal is expected to close in the first half of 2012.

Founded in 1986 and based in St. Louis, Missouri, Express Scripts reported profits of $334 million in the second quarter of 2011 on revenues of $11.36 billion.

Medco, based in Franklin Lakes, New Jersey, had profits of $342 million on revenues of $17 billion in the same quarter.

Related Stories

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.